Professor Donald BerryProfessor of Biostatistics, University of Texas M.D. Anderson Cancer Center
Donald Berry is a professor in the Department of Biostatistics of the University of Texas M.D. Anderson Cancer Center. In 1999 he was founding Chair of this department and in 2006 he was founding Head of the Division of Quantitative Sciences, including the Department of Bioinformatics and Computational Biology. He previously served on the faculties of the University of Minnesota and Duke University. He held endowed faculty positions at Duke University and at M.D. Anderson. View more.
Dr. Berry received a Ph.D. in statistics from Yale University. A principal focus of his research is the use of biomarkers in cancer and other diseases for learning which patients benefit from which therapies, based on -omics and phenotype. In particular, he designed and is a co-PI of I-SPY 2 www.ispy2.org, a Bayesian adaptive platform clinical trial in high-risk early breast cancer whose goal is matching experimental therapies with patient subsets that are defined by tumor molecular characteristics.
Through Berry Consultants, LLC he has designed many innovative clinical trials in all therapeutic areas for pharmaceutical and medical device companies, for NIH cooperative groups, and for international consortia. He serves on the PDQ Screening and Prevention Board of the National Cancer Institute for which he received the National Institutes of Health Award of Merit in 2010. Dr. Berry is the author of several books on statistical theory and methodology and has over 400 publications, including first-authored articles in major medical journals.
In 2014 he was named a Thomson Reuters Highly Cited Researcher in Clinical Medicine and listed as one of The World's Most Influential Scientific Minds in ScienceWatch.com. Dr. Berry has been the principal investigator for numerous research grants from the National Institutes of Health and the National Science Foundation. He is a Fellow of the American Statistical Association and the Institute of Mathematical Statistics.
Professor Dame Sally DaviesChief Medical Officer, UK
Previous career highlights include developing the National Institute for Health Research. Sally also chairs the UK Clinical Research Collaboration, and is a member of the board of the Office for Strategic Co-ordination of Health Research and the Medical Research Council the World Health Organization (WHO) Global Advisory Committee on Health Research the International Advisory Committee for A*STAR, Singapore the Caribbean Health Research Council. In addition, Sally advises many organisations on research strategy and evaluation - including the Australian National Health and Medical Research Council – Presentation to be made via video.
Professor Richard HortonEditor in Chief, The Lancet
Richard Horton (BSc MB FRCP FMedSci) was born in London and qualified in medicine from the University of Birmingham in 1986. He completed his general medical training in Birmingham before moving to the liver unit at the Royal Free Hospital. In 1990, he joined The Lancet as an assistant editor and moved to New York as North American editor in 1993. Two years later he returned to the UK to become Editor-in-Chief. View more.
He was the first President of the World Association of Medical Editors and is a Past-President of the US Council of Science Editors. He is an honorary professor at the London School of Hygiene and Tropical Medicine, University College London, and the University of Edinburgh. He is a Fellow of the Royal College of Physicians and a Founder Fellow of the UK's Academy of Medical Sciences.
In 2005 he was a member of the working party and subsequently wrote the report for the Royal College of Physicians' inquiry into the future of medical professionalism – Doctors in Society. He currently chairs the Royal College of Physicians' Working Party on Physicians and the Pharmaceutical Industry; co-chairs a WHO Scientific Advisory Group on Clinical Trials Registration; is a Council Member of the Global Forum for Health Research; is a Board Member of the Health Metrics Network; sits on the External Reference Group for WHO's Research Strategy; and is an External Advisory Board Member for the WHO European Region.
In 2004, The Lancet won the UK's Medical Publication of the Year and, in 2007, he received the Edinburgh Medal for professional achievements judged to have made a significant contribution to the understanding of human health and wellbeing. In 2008, he was appointed a Senior Associate of The Nuffield Trust, a think tank for research and policy studies in health services. He has a strong interest in issues of global health. He has been a medical columnist for The Observer and writes regularly for the Times Literary Supplement and New York Review of Books. A book about controversies in modern medicine, Second Opinion, was published in 2003.
Ms Susan MarlinPresident and CEO Clinical Trials Ontario
Susan Marlin is the President and CEO of Clinical Trials Ontario, a not-for-profit organization established by the Province of Ontario in 2012 to make Ontario a preferred location for global clinical trials while maintaining the highest ethical standards. As the first President and CEO of the organization she has led the establishment of the organization and the development and implementation of a province-wide streamlined research ethics review system. Prior to serving in this position she spent a decade working in research administration at Queen's University, most recently serving as the Associate Vice-Principal of Research. View more.
In this role she supported research initiatives by pursuing funding and partnership opportunities and by leading university-wide research support and compliance programs. Before this Susan worked with the National Cancer Institute of Canada Clinical Trials Group for many years, initially coordinating cancer clinical trials and later leading the development and implementation of the Ethics and Regulatory Office.
Susan has been actively engaged in research ethics over the years and has served on several research ethics committees. She served as President of the Canadian Association of Research Ethics Boards, as a member of the Canadian Institutes of Health Research (CIHR) Research Integrity Committee, the Ontario Cancer Research Ethics Board and the Tri-Agency Panel on the Responsible Conduct of Research. Susan currently serves on several boards and committees supporting clinical research and innovation in health care including the National Advisory Group for the Canadian Clinical Trials Coordinating Centre, the Management Team for the Ontario SPOR (Strategy for Patient Oriented Research) Management Team, the Health Technologies Exchange Harmony Project Advisory Board and the Toronto Region Human Health Sciences Committee.
Susan was born and raised in Halifax, Nova Scotia. She holds a BSc (Hons) in Psychology from Dalhousie University, and an MSc in Community Health and Epidemiology from Queen's University. She was awarded the Queen's Elizabeth II Diamond Jubilee medal in 2012 in recognition of her work in support of military and veteran health research.
Professor Kathy RowanDirector of Scientific & Strategic Development
Intensive Care National Audit & Research Centre (ICNARC)
In 1994, Kathy established the Intensive Care National Audit & Research Centre (ICNARC), a not-for-profit organisation in the UK, to facilitate improvements in the structure, process, outcomes and experiences of critical care for patients and for those who care for them. ICNARC undertakes a broad programme of clinical audit and research, both nationally and internationally. View more.
From 1994 to 2013, Kathy led and directed ICNARC and, in 2004, was awarded the Humphry Davy Medal by the UK Royal College of Anaesthetists as a mark of distinction for her significant contribution to critical care. Following appointment of a Chief Executive in early 2014, Kathy now acts as ICNARC’s Director of Scientific & Strategic Development and remains Director of its UK Clinical Research Collaboration Registered Clinical Trials Unit. Kathy is an Honorary Professor in the Department of Health Services Research and Policy at the London School of Hygiene & Tropical Medicine and in the Division of Research Strategy at University College London.
Register a Sessions Register a Workshops Submit Abstract
|Call for abstracts
Abstract submission has now closed
21st October 2016
|Abstract submission deadline
14th November 2016
|Notification of acceptance of abstract
21st November 2016
13th-17th October 2016
|Registration Fees is
RS 300 / session
|Your registration will only be confirmed and a place reserved once your registration fee has been received|